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Summary
Rifamycins, the clinically important antibiotics, target
bacterial RNA polymerase (RNAP). A proposed mech-
anism in which rifamycins sterically block the exten-
sion of nascent RNA beyond three nucleotides does
not alone explain why certain RNAP mutations confer
resistance to some but not other rifamycins. Here we
show that unlike rifampicin and rifapentin, and con-
tradictory to the steric model, rifabutin inhibits forma-
tion of the first and second phosphodiester bonds.
We report 2.5 Å resolution structures of rifabutin and
rifapentin complexed with the Thermus thermophilus
RNAP holoenzyme. The structures reveal functionally
important distinct interactions of antibiotics with the
initiation  factor. Strikingly, both complexes lack the
catalytic Mg2+ ion observed in the apo-holoenzyme,
whereas an increase in Mg2+ concentration confers
resistance to rifamycins. We propose that a rifamycin-
induced signal is transmitted over 19 Å to the RNAP
active site to slow down catalysis. Based on struc-
tural predictions, we designed enzyme substitutions
that apparently interrupt this allosteric signal.
Introduction
Bacterial RNAP holoenzyme, composed of a catalytic
core (α2ββ’ω subunits) and a σ-specificity factor, binds
to a promoter and initiates reiterative abortive synthesis*Correspondence: dmitry@uab.eduof short RNA products. Once a stable,R8 nt-long RNA
primer is synthesized to form an 8–9 bp RNA/DNA hy-
brid, RNAP leaves the promoter and enters a highly
processive elongation state that persists for thousands
of nucleotide addition cycles. Rifamycins (Rifs) that
were discovered nearly 50 years ago as fermentation
by-products of Streptomyces mediterranei sp. (for a
comprehensive review, see Floss and Yu, 2005) strongly
inhibit synthesis of short RNAs but do not affect stable
transcription elongation complexes (Sippel and Hart-
mann, 1970).
Rifamycins still retain their prominence as the first-
line antibiotics in combating tuberculosis; however,
their efficiency and versatility is limited by the rapid emer-
gence of resistant bacteria. To overcome this problem,
one needs to understand the detailed mechanisms of
both the Rifs’ action and the bacterial resistance to
these drugs. Rifs belong to a group of ansamycin anti-
biotics that contain an aromatic naphthoquinone moi-
ety (ansa ring) with a variable “tail” attached to the C3
and/or C4 positions (Figure 1A). The range of antibacte-
rial activity for different C3/C4-substituted Rifs can eas-
ily span several orders of magnitude (Maggi et al.,
1965). Therefore, it is not surprising that most of the
efforts in drug design were concentrated on the cre-
ation of new C3/C4 substituted variants. Three Rifs are
currently used in therapy: rifampicin (RFP), rifapentin
(RPN), and rifabutin (RFB). However, functional in vitro
analysis of the inhibitory mechanism focused only on
RFP. The structure of the Thermus aquaticus core RNAP
(taqRNAP) in complex with RFP determined at 3.3 Å
resolution (Campbell et al., 2001) showed that, in sup-
port of genetic data (Boyd and Zillig, 1974; Jin and
Gross, 1988; Kawai et al., 1976; Ovchinnikov et al.,
1983; Severinov et al., 1993, 1994), RFP binds to a site
on the β subunit located in the path of the nascent RNA.
This suggested an intuitive and simple model in which
RFP sterically blocks synthesis of an RNA product
longer than 3 nt, and all β substitutions that confer re-
sistance to RFP do so by distorting its binding pocket.
However, several observations cannot be easily rec-
onciled with the simple steric hindrance mechanism
(Table 1). Some of these discrepancies could be due to
the fact that the structure was obtained with a non-
physiological RFP target (core enzyme); indeed, cross-
linking of the Rif tail to the σ subunit has been reported
(Mustaev et al., 1994; Stender et al., 1975). Most impor-
tantly, this model fails to account for the existence of
rpoB mutants that are resistant to RFP and RPN yet
sensitive to RFB in vivo (Wichelhaus et al., 2001; Wil-
liams et al., 1998) since the tail, the only variable part
of the compounds tested, does not make any contacts
to RNAP (Campbell et al., 2001). Interestingly, substi-
tutions that confer differential sensitivity phenotypes
cluster far from the tail in the structure.
In order to resolve these lingering disparities, we pur-
sued three parallel approaches: structural, biochemi-
cal, and genetic. First, we demonstrated that the tails
confer differential effects on transcription in vitro. Sec-






































Figure 1. Inhibition of E. coli RNAP by Rifs In Vitro Depends on
Their Mode of Tail Attachment
(A) Two classes of rifamycins with tails attached to C3 (red, RFP— o
rifampicin, RPN—rifapentin) and C3/C4 (blue, RFB—rifabutin,
nRMX—rifamexyl) positions of the ansa ring (naphtohydroquinonic
bchromophore spanned by an aliphatic bridge).
s(B) RNA synthesis as a function of Rifs’ concentrations. (Top) A
representative gel panel, (bottom) effects of Rif tail (shown on the o
right) on ApUpCpG and ApUpC synthesis. The error bars are omit- l




aof RPN and RFB in complex with the T. thermophilus
RNAP holoenzyme (ttRNAP) and performed systematic t
canalysis of Rif-RNAP contacts. Third, we showed that
distinct contacts of RPN and RFB tails to σ correlated the native apo-holoenzyme in this crystal form at 2.8 Å
Table 1. Observations that Cannot Be Easily Explained by the Steric Block Model
Observation Reference
Inhibition of the first phosphodiester bond formation McClure and Cech, 1978
RFP-resistant substitutions distant from the inhibitor binding site Jin and Gross, 1988
Inhibition of GreA-facilitated cleavage and pyrophosphorolysis in binary complexes Altmann et al., 1994
by RFP
β substitutions that are resistant to RFP and RPN but sensitive to RFB Wichelhaus et al., 2001; Williams et al., 1998
Differential RFP resistance of holoenzymes containing σ70 and σ32 initiation factors Wegrzyn et al., 1998ith their patterns of RNAP inhibition. While our data
o not exclude the steric model as a critical step of
he Rifs’ inhibition mechanism, they argue that Rifs also
nhibit transcription at earlier steps through an alloste-
ic signal that disfavors binding of the Mg2+ ion in the
ctive site, thus slowing down catalysis and facilitating
issociation of short RNA transcripts. This model ade-
uately explains observations that are at odds with the
teric-block mechanism.
esults and Discussion
ifferent Mode of Tail Attachment Confers
ifferential Effects on Transcription
ifferential bactericidal effects of Rif tails were thought
o result from different permeability of bacterial cell
alls to individual rifamycins (Brufani et al., 1982). How-
ver, direct differential effects on transcription were
lso noted (Wehrli and Staehelin, 1969). In order to di-
ectly assess the impact of tail variations, we compiled
set of rifamycins that differ in the structure and posi-
ion of tail attachment and tested their effects on tran-
cription by E. coli RNAP in vitro (Figure 1B). Consistent
ith previous reports (McClure and Cech, 1978), RFP
nhibited the formation of the second phosphodiester
ond when transcription was initiated with ApU dinu-
leotide and thus led to a decrease in ApUpCpG syn-
hesis but did not inhibit the ApUpC synthesis. This pat-
ern of inhibition is shared by all rifamycins tested with
ails attached to C3 (Figure 1B and data not shown).
n contrast, RFB and rifamexyl (RMX), whose tails are
ttached to C3/C4 positions, inhibited even the first
hosphodiester bond formation (Figure 1B).
tructures of RNAP/Rif Complexes
o ascertain whether structurally different Rifs make
istinct contacts with the enzyme, we obtained crystals
f ttRNAP holoenzyme with Rifs from each class, RPN
nd RFB. We chose RPN for structural studies because
f its greater stability in solution and because we did
ot detect any qualitative or quantitative differences
etween RFP and RPN in either in vivo or in vitro as-
ays. Though the crystals used in these studies were
btained in the same crystallization conditions and be-
onged to the same space group as the previously re-
orted structures, they exhibited a substantial increase
w2%) in all unit cell parameters that make them non-
somorphous with the previous crystals (Vassylyev et
l., 2002). To ensure adequate comparison of the
tRNAP/Rif complexes with the apo-holoenzyme, we
ollected diffraction data and refined the structure of
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353Table 2. Data Collection and Refinement Statistics
Apo-holoenzyme RNAP/RPN RNAP/RFB
Space group P65a
Unit cell parameters (Å) a = b = 239.5, c = 253.1
Resolution (Å) 25.0–2.8 (2.90–2.80)b 25.0–2.5 (2.59–2.50) 25.0–2.5 (2.59–2.50)
Reflections (Total/Unique) 562759/184546 876633/260112 727855/257186
I/σI 25.2 (2.7) 20.2 (2.3) 17.2 (2.3)
Rmerge 6.6 (43.6) 6.5 (46.3) 7.4 (43.8)
Completeness (%) 92.0 (77.5) 92.6 (72.4) 91.2 (78.8)
Refinement
Space group P32
Resolution (Å) 25.0–2.8 (2.90–2.80)b 25.0–2.5 (2.59–2.50) 25.0–2.5 (2.59–2.50)
Reflections used 366401 517106 511160
R factor (%) 23.1 (32.7) 23.0 (33.9) 22.5 (31.7)
Rfree (%) 26.8 (36.5) 26.7 (35.6) 25.7 (34.5)
RMSD bond length (Å) 0.016 0.016 0.015
RMSD bond angles (°) 1.90 1.88 1.86
RMSD improper angles (°) 1.10 1.10 1.10
Number of protein atoms 53574 53574 53574
Number of water molecules 5117c 6399 6845
Number of rifamycins’ atoms 0 126 122
Number of active-site Mg2+ ions 2 0 0
Number of other Mg2+ ions 0d 487 562
Number of Zn2+ ions 4 4 4
Rmerge = ΣhklΣj|Ij(hkl) − <I(hkl)>|/ΣhklΣj <I(hkl)>, where Ij(hkl) and <I(hkl)> are the intensity of measurement j and the mean intensity for the
reflection with indices hkl, respectively. R factor, free=Σhkl||Fcalc(hkl)| − |Fobs(hkl)||/Σhkl|Fobs|, where the crystallographic R factor is calculated
including and excluding reflections in the refinement. The free reflections constituted 4% of the total number of reflections. RMSD—root
mean square deviation. I/σ(I)—ratio of mean intensity to a mean standard deviation of intensity.
a The crystals belong to P32 space group with a perfect (50%) merohedral twinning mimicking P65 space group. The data were therefore
processed in P65 space group and were expanded to P32 space group for refinement.
b The data for the highest resolution shell are shown in brackets.
c The water molecules were added by the standard alternating cycles of the water pick (water molecules were picked at 3σ level in the
difference |Fobs − Fcalc| ED map) and water delete (water molecules with correlation coefficients less than 0.45 and peak heights less than
1.25σ in the |2Fobs − Fcalc| ED map were deleted) procedures. The water molecules were added until Rfree dropped by less than 0.5% at the
last cycle. A relatively large number of water molecules may account for a large solvent content of the crystal (~77%) and also for very mild,
nearly physiological conditions at which crystals were grown that might allow better specific hydration of the RNAP molecules.
d The water molecules with low B factor values (< 20 Å2), characterized by more than 5σ level in the |2Fo−Fc| ED map and having at least one
oxygen ligand, were converted into Mg2+ ions for the RNAP/Rifs complexes but were not included in the native holoenzyme structure in view
of the lower resolution of the diffraction data.resolution (R factor = 23.1%, Rfree = 26.8%) in addition
to the RNAP/RPN (R factor = 23.0%, Rfree = 26.7%) and
RNAP/RFB (R factor = 22.5%, Rfree = 25.7%) structures
refined at 2.5 Å resolution (Table 2 and Figure S1). This
crystal form exhibited only one significant difference
from published ttRNAP structures—the bridge helix
was uniform (straight), in contrast to the previously ob-
served, locally distorted (with the two residues flipped
out of the helix) conformation (Vassylyev et al., 2002).
This difference, however, was observed in all three
structures and therefore cannot be attributed to the
Rifs’ binding (Supplemental “RNAP structure”).
As the uniform conformation of the bridge was pre-
viously observed only in eukaryotic RNAP, the finding
that both conformations can exist in the same (bacte-
rial) system further supports the earlier hypothesis that
the local flipping of the bridge helix is universal for
multisubunit RNAPs and may mediate DNA transloca-
tion during transcription (Cramer et al., 2001; Vassylyev
et al., 2002).
Both RNAP/Rif complexes contained two molecules
in the asymmetric unit designated as RNAP1 and RNAP2,
as observed previously (Artsimovitch et al., 2004; Vas-
sylyev et al., 2002). Surprisingly, although high concen-
trations of magnesium formate (w15 mM) and a nearly
physiological pH (6.5) were used for crystallization, thehigh-affinity Mg2+ ion, bound to the catalytic β’ Asp res-
idues (positions 460, 462, and 464; throughout the text,
the Escherichia coli numbering is used) was absent
from all four independent RNAP molecules from the two
Rif complexes. In contrast, this ion was observed in all
previous multisubunit RNAP structures, as well as in
isomorphous apo-holoenzyme crystals as revealed by
the difference electron density (ED) built using |Fnati −
Frif| coefficients, where Fnati and Frif are the structure
factors for the apo-holoenzyme and Rif complexes,
respectively, and the phases are from the partially re-
fined apo-holoenzyme structure (Figure 2A). The same
phases, but with reversed |Frif − Fnati| coefficients, re-
vealed the clear ED for RPN and RFB (Figures 2B and
2C) that allowed unambiguous fit of the antibiotics in
the complexes. RPN and RFB bound to the same site
on ttRNAP as did RFP in the taqRNAP/RFP complex
(Campbell et al., 2001), with positions and contacts of
the two ansa rings nearly superimposable (Figure 2D).
Rifamycins’ Binding to RNAP
The Rif binding site is highly conserved among bacte-
ria: amino acid sequences in the vicinity of the Rif con-
tacts are identical between T. thermophilus and T. aquat-
icus RNAPs, whereas the evolutionarily distant E. coli
sequence is 82% identical and 90% homologous to
Cell
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plexes
(A–C) Experimental 3.5 Å resolution |Fnati −
FRPN| (A) (3.5σ level), and |FRPN − Fnati| (B) and
|FRFB − Fnati| (C) (3.0σ level both) omit ED
maps (green) superimposed on the RNAP1/
Rifs structures.
(D) Superposition of the RPN (magenta) and
RFB (green) atomic models. The RNAP1
structure is shown by the white ribbon dia-
gram, the active-site Asp side chains (cyan)
are represented by a balls-and-sticks model.
In this and the following structural figures,
the same color scheme is used for the RNAP
subunits and the Rifs’ atomic models: β—light
yellow, β#—white, Rifs—pink.both (Figure 3A), indicating that structural results ob- t
itained with T. thermophilus RNAP would be applicable
to other bacterial species. RPN differs from RFP by only 3
ea few extra atoms that make no interactions with the
protein, allowing for direct comparison between the o
bttRNAP/RPN(RFB) and taqRNAP/RFP complexes at
the atomic level. Similar to those in the taqRNAP/RFP w
dcomplex, most contacts in the ttRNAP/Rif complexes
were observed between the β subunit residues and the β
oansa rings (Figures 3B and 3C). However, the network
of the polar interactions with the ring system was much t
emore extensive, comprising eighteen versus eight hy-
drogen bonds in the taqRNAP/RFP complex (Campbell v
Ret al., 2001), with three additional bonds made by σ in
RNAP1 (Figures 3B and 3C and Figure 4A). a
RNumerous screens for Rif-resistant isolates have
been performed, yielding important insights into rifam- s
opicin action (Jin and Gross, 1988; Romero et al., 1973;
Severinov et al., 1993, 1994; Telenti et al., 1993); how- r
tever, because of disparities in assay conditions and the
scoring of the resistant phenotypes, we performed sat- s
purating mutagenesis of the E. coli rpoB regions associ-
ated with Rif resistance in vitro and in vivo to evaluate e
sthe contribution of each β residue in contact with Rif
(Figure 3A). The crucial differences between the ttRNAP t
vand taqRNAP polar contacts with Rifs involve βArg529,
βGln513, and βHis526, which form three, four, and two a
bhydrogen bonds with four Rif oxygen atoms in ttRNAP,
respectively; only one such bond is formed by each of s
tthese residues in taqRNAP. These oxygen atoms are
known to be essential for Rif inhibition (Bacchi et al., p
1998) and are rigidly fixed by the Rifs’ backbone. Fur-
thermore, βArg529, βGln513, and βHis526 form addi- rional polar contacts with each other, thus creating an
ntricate RNAP/Rifs recognition pattern (Figures 3B and
C). Such a concerted mode of binding implies that the
xclusion of a single interacting group (either in RNAP
r Rifs) would not only eliminate its specific contacts
ut also would likely disturb the entire interaction net-
ork and lead to a dramatic loss in binding affinity. Un-
erscoring their functional importance, substitutions of
Arg529, βGln513, and βHis526 side chains for smaller
nes conferred strong Rif resistance, whereas elimina-
ion of other RNAP/Rif polar interactions elicited smaller
ffects (Figure 3). The ttRNAP/Rif structures also re-
ealed additional contacts of βArg143 and βGln510 with
ifs. Notably, the hydrogen bond between taqβAsp516
nd O2 of Rif, which has been invoked to explain strong
FP resistance of the βAsp516 mutants, was not ob-
erved in the ttRNAP complexes and the substitution
f the E. coli βAsp516 for Ala did not elicit strong RFP
esistance (Figure 3A). These disparities could be at-
ributed to the lower resolution of the taqRNAP/RFP
tructure; indeed, a brief analysis of the recently im-
roved structure of taqRNAP/RFP complex (Campbell
t al., 2005) indicates that both the overall taqRNAP
tructure and the Rif binding pocket resemble the
tRNAP conformation far more closely than the pre-
iously published taqRNAP/RFP complex (Campbell et
l., 2001). In particular, the βAsp516/RFP hydrogen
ond is also missing in the updated taqRNAP/RFP
tructure. However, significant differences in Rifs con-
acts still remain between the ttRNAP/Rifs and the im-
roved taqRNAP/RFP structures.
The ttRNAP/RPN and ttRNAP/RFB complexes also
evealed contacts between the antibiotics and the σ
Allosteric Control of Transcription by Rifamycins
355Figure 3. RNAP/Rifs Binding
Residues making polar (cyan) and hydrophobic (green) interactions with the Rifs’ ansa ring are shown.
(A) The Rif-resistant substitutions characterized in this study are shown on top of the sequence alignment between E. coli and T. thermophilus
β subunits.
(B and C) Three-dimensional stereo (RNAP1/RPN model was used) and schematic drawings show the RNAP/ansa ring hydrogen bonding
using the cyan dashed lines or arrows, and the van der Waals contacts using green dashed lines.subunit that were strikingly different in RNAP1 and
RNAP2 (Figures 4A and 4B). In RNAP1, the σ hairpin
loop (σHL, E. coli σ70 residues 508–519) closely ap-
proached bound Rifs while the σAsp513 side chain
formed nearly identical hydrogen bonds with O4 and
O5 of RPN and RFB. In RNAP2, the σHL was distant
from the rings and interacted specifically with the RFB
tail; in contrast, it formed only nonspecific van der
Waals contacts with RPN. At the same time, the qualityof the ED, nearly equal B factors, and nearly identical
orientations suggest that RFB and RPN bind equally
well to RNAP1 and RNAP2 and that their contacts with
σHL contribute little to the binding affinity, a prediction
which is supported by our biochemical data (see be-
low). The proximal and distal orientations (with respect
to the Rif binding site) of the σHL were observed in all
previous ttRNAP structures and thus are likely unre-




























Figure 4. Interactions of the σHL with Rifs and Effects on Tran- R
scription t
(A and B) Interactions of the σHL (magenta) with the RPN/RFB ansa o
ring in RNAP1 (A) and with the RFB tail in RNAP2 (B). a
(C) Effects of the σHL and βS531F substitution on ApUpCpG and sApUpC synthesis at the T7A1 promoter upon addition of RPN or
hRFB to 10 g/ml. Data shown are the mean and SD (n = 3).
R
s
cdistinct physiologically relevant conformers that exist
hin dynamic equilibrium in the free holoenzyme. This
σequilibrium, however, could be shifted upon formation
(of the transcriptionally competent open complex in the
wpresence of Rif.
tThe structural data allow us to draw one important
Sconclusion: the differential effects of RPN and RFB on
ntranscription cannot be adequately explained by the
Rsteric model. Indeed, the ansa rings of both RFB and
tRPN occupy the same site on RNAP and thus should
ssterically block the nascent RNA in identical fashion.
iFurthermore, as reported above, RPN blocks the sec-
ond, while RFB inhibits the first bond formation; how-
ever, in the complex with RNAP, the RFB tail is located M
Tfarther from the active site and thus farther from the
growing RNA/DNA hybrid (Figure 2D), suggesting com- R
Fpletely opposite effects in light of the steric model.
The RNAP/Rif complex models suggest several hy- t
(potheses that can be verified experimentally. First,
since contacts of σHL with the RFB tail constitute the c
aonly difference in RNAP binding between RFB and
RPN, σ could be responsible for distinct patterns of c
ttranscription inhibition by Rifs (Figure 1B). Second,
binding of Rifs apparently leads to a loss of the cata- o
elytic Mg2+ ion from the active site (Figure 2A). As Rifs
bind nearly 20 Å from the RNAP active site, this sug- i
tgests that an allosteric signal culminating in Mg2+ dis-
placement is transmitted from the Rif binding site to che catalytic Asp residues. Thus an increase in Mg2+
oncentration should protect RNAP against inhibition
y Rifs. Indeed, over 30 years ago such an effect was
eported for RFP (Kerrich-Santo and Hartmann, 1974).
hird, the structural data might allow us to trace the
ath along which the allosteric signal is transmitted,
hich then could be disrupted through engineered sub-
titutions in RNAP.
eletion of the HL Has Distinct Effects
n Inhibition by Rifs
ur structural data pointed to a rather dynamic nature
f Rifs interactions with σHL, complicating assignment
f the differential effects of RPN and RFB on transcrip-
ion to a particular residue. Therefore, to test the first
ypothesis, we deleted residues 507 through 519 in the
70 subunit of E. coli RNAP (σHL) to eliminate all the
nteractions of σHL with Rifs. We predicted that this
eletion, which does not confer gross transcriptional
efects (Zenkin and Severinov, 2004), would not alter
he common features of the RFB and RPN mechanisms
such as inhibition of the ApUpCpG synthesis) but
ould affect the RFB-specific inhibition of the first
hosphodiester bond formation (ApUpC synthesis). In-
eed, σHL specifically conferred resistance of the ApUpC
ormation to RFB (Figure 4C): synthesis of ApUpC by
he holoenzyme assembled from the wild-type core
NAP and σHL was as efficient as ApUpC synthesis by
he holoenzyme assembled from the βS531F core (one
f the strongest RFP-resistant substitutions known)
nd the wild-type σ70 but was inhibited by RFB during
ubsequent steps. In contrast, a deletion in the HL in-
ibited formation of the first bond in the presence of
PN (Figure 4B). Though we do not understand the ba-
is for this observation, the effect of the HL deletion
ould explain the differential response to structurally
omologous RFP of the holoenzymes with alternative
factors, which likely have distinct conformations of σHL
Wegrzyn et al., 1998). On the other hand, in agreement
ith structural predictions, the σHL holoenzyme bound
o RFP as well as did the wild-type RNAP (Figure S2).
ince σHL is located too far to interact directly with the
ascent RNA/DNA hybrid, the apparent σ-dependent
if effect on the first bond formation is likely caused by
he allosteric σ-mediated signal that modulates cataly-
is and correlates with the loss of the active site Mg2+
on.
g-Dependent Protection against Rifamycins
o test the second hypothesis, we ascertained whether
if inhibition can be overcome by elevated Mg2+ levels.
irst, we studied survival of the E. coli rpoBN518D cells in
he presence of Rif as a function of Mg2+ concentration
Figure 5A). Addition of 25 mM MgSO4 did not increase
ell viability in the absence of inhibitor but rather led to
dramatic, 200-fold increase in the number of viable
ells on RFP plates, whereas intermediate Mg concen-
rations produced lesser effects. Similar effects were
bserved in the presence of RPN or RFB and with sev-
ral other rpoB alleles (data not shown). The increase
n viability could be due to either the attenuated inhibi-
ion by RFP or a decrease in cell permeability to rifamy-
ins. Control experiments demonstrated that the up-
Allosteric Control of Transcription by Rifamycins
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tect RNAP against Inhibition by Rifs
(A) Mg-dependent survival of the E. coli cells
carrying the plasmid-encoded IPTG-induc-
ible rpoBN518D allele (see Experimental Pro-
cedures) in the absence or in the presence of
RFP (50 mg/l); MgSO4 was added to 25 mM.
(B) Effect of Mg2+ concentration on RNA
synthesis in the presence of Rifs and RFP
binding in vitro. Synthesis of the halted A29
transcription complexes was measured on
pIA171 template with 100 M ApU, 2.5 M
GTP, 1 M CTP, 10 Ci of [α32P]-CTP (3000
Ci/mmol) at 37°C for 15 min in TGA buffer
containing different concentrations of Mg2+.
Inhibition of A29 RNA synthesis by Rifs (rela-
tive to A29 synthesis in the absence of inhib-
itor, defined as 0% inhibition) was deter-
mined with RFB at 1 g/ml (filled circles),
RFP at 0.5 g/ml (filled triangles), or RPN at
0.5 g/ml (open circles). To determine reten-
tion of 3H-labeled RFP (filled squares), stable
initiation complexes were formed on pIA171
template during 15 min incubation at 37°C in
the presence of 100 M ApU; the concentra-
tion of Mg2+ was then adjusted between 0.4
and 10 mM and RFP retention was measured
as described in Experimental Procedures.
Binding at 0.4 mM Mg2+ was taken as 100%.
Data shown are the average and spread of
two measurements.take of 3H-labeled RFP did not vary over the same
MgSO4 range (data not shown). Second, we tested the
effect of Mg titration on transcription by E. coli RNAP
in vitro (Figure 5B). Increase of Mg2+ from 0.25 to 10
mM led to a decrease in inhibition of RNA synthesis by
RPN or RFB from 80% to 0% (as compared to no Rif).
Importantly, this protection is not absolute—elevated
Mg2+ levels simply shift upward the inhibitory concen-
tration of Rif and thus confer partial relief of inhibition
in vivo and in vitro. This effect could be due to the dis-
placement of RFP from the transcription complexes by
Mg2+ ions. However, RFP binding to the initiation com-
plexes did not change over the same range of Mg2+
concentrations (Figure 5B).
-Mediated Allosteric Signal
The proposed σ-mediated signal explains the Rif-
induced allosteric effect on the first bond formation.
However, the σHL RNAP is susceptible to inhibition at
the consecutive steps, suggesting another allosteric
pathway from the Rif binding to the RNAP active site.
Apart from the already noted contacts with the σHL,
the Rif binding site consists exclusively of β subunit
residues. Over the years, many Rif-resistant rpoB mu-
tants were isolated as a result of mutagenesis and se-
lection or during analysis of clinical samples. While the
majority of substitutions occurred at positions involved
in direct contact with the rifamycin body, several vari-ants, such as D516V, N519K, S522L, or R687H, do not
fall into this category. Interestingly, the first three mu-
tants (the fourth was not tested) are resistant to RFP
but very sensitive and thus still bind to RFB (Wichel-
haus et al., 2001; Williams et al., 1998). Since the altered
residues cluster on the side of the invariant ansa ring
that lies opposite the tail, their effects cannot be easily
explained by the earlier proposal that Rif resistance al-
ways stems from a loss of binding to a distorted Rif
binding pocket (Campbell et al., 2001). Of these resi-
dues only βAsp516 is located within the interacting dis-
tance with Rifs in the ttRNAP/Rif structures. It, however,
makes only weak van der Waals interactions with the
Rifs’ backbone (Figures 3B and 3C); thus substitutions
to a smaller Val or isosteric Asn should not dramatically
affect the Rif affinity. Indeed, these substitutions con-
ferred strong resistance to RFP in vivo while retaining
sensitivity to RFB in vivo and significant binding (w25%
of wild-type RNAP) to RFP in vitro (Figure 3A and Sup-
plemental Data, Binding of RFP to RNAP Variants and
Figure S2). In contrast, three RNAP variants that dis-
played a dramatic loss of RFP binding (3%–5% of wild-
type RNAP; Figure 3A and Supplemental Data, Binding
of RFP to RNAP Variants and Figure S2) were substan-
tially more sensitive (10- to 1000-fold) to RFP than
βD516V/N enzymes. Two of these variants (as well as
the βD516V/N RNAP mutants) did not confer significant
growth defects in the absence of antibiotics, thereby
Cell
358suggesting that their strong resistance to RFP (equal to p
wthat of βD516V/N) cannot be attributed solely to the lower
fviability (see details in Supplemental Data, Binding of
pRFP to RNAP Variants). Together, these observations
psuggest that βAsp516 affects Rif action allosterically.
eTaking βAsp516 as a reference, we have traced a puta-
otive pathway from this residue toward the active site.
tRemarkably, βArg687 (Thr in T. thermophilus), which
fhas direct contacts with βAsp516 and whose substitu-
otion to His is RFP resistant (Jin and Gross, 1988), lies
sin this path (Figure 6A). Other residues include βMet685
aand βLeu1235, which form a hydrophobic core with
βLys1066 and βLys1074, the latter two residues making
pdirect contacts to the active site loop. We constructed
sa βL1235A variant that lies in the putative signal trans-
tduction pathway far away from both the Rif binding and
sactive sites. To provide further validation of the mod-
oeled allosteric pathway, we also substituted two other
tresidues (βN684A and βM681A) that are located near
(βLeu1235 and at approximately the same distance from
tthe Rif binding site but do not contribute to the network
dof interactions allosterically linking the Rif binding and
eactive sites.
oAccording to our expectations, we found that βL1235A
ssupported E. coli growth in the presence of RFP,
pwhereas the other two “off-pathway” variants did not
((Figure 6B and data not shown). Although the RFP-
(resistant mutant grew slowly in the presence and
(absence of inhibitors, the slow growth per se was insuf-
wficient to confer RFP resistance: two β variants that
2contained substitutions of residues 1105 and 1106 dis-
tant from both the RFP binding pocket and the alloste-
cric pathway grew equally slowly but remained sensitive
cto RFP (Figure 6B). We purified βL1235A RNAP and
eshowed that while it was resistant to RFP inhibition in
tvitro, its affinity was even higher than that of the wild-
itype RNAP, in contrast to RFP-resistant βQ513P enzyme
sthat did not retain the inhibitor above the background
Rlevel (Figure 6C). These data support the hypothesis
ethat the βLeu1235 residue is necessary to transmit the
(allosteric signal but is dispensable for Rif binding.
p
β
Mechanism of Inhibition of Transcription r
by Rifamycins i
Altogether our data suggest that Rif binding to RNAP e
induces an allosteric signal that is transmitted to the p
RNAP active site and disfavors binding of the major t
catalytic Mg2+ ion. The loss of the Mg2+ ion slows down a
the reaction, which in turn likely results in spontaneous b
dissociation of the short, unstable RNA/DNA hybrids t
(Schulz and Zillig, 1981). Although we do not rule out w
the steric block as a component of the inhibition mech- i
anism, the steric block alone seems insufficient to in- i
hibit transcription: both Mg2+ and certain RNAP substi- m
tutions (βD516V/N, σHL, and βL1235A) confer resistance to i
RFP but do not eliminate the binding of antibiotic,
which presumably is still bound in the path of grow- b
ing RNA. r
Our data are consistent with the existence of at least s
two allosteric pathways from Rif to the RNAP active t
site: the σ pathway affects the first, whereas the β path- c
way modulates the second/third phosphodiester bond M
sformation. Activation of the σ pathway is apparently de-endent on the orientation of the Rif tail. Indeed, RFB,
hose tail has unique contacts with σHL, blocks the
irst bond formation, thereby relying largely on the σ
athway. Truncation of σHL, which likely disturbs the σ
athway, restores the first bond formation in the pres-
nce of RFB. At the same time, σ deletion had no effect
n the inhibition of the second bond by either Rif. In
urn, mutations that disrupt the β pathway (βD516V) con-
erred resistance to RFP, which inhibits only the sec-
nd, but not the first, bond formation, while retaining
ensitivity to RFB (Wichelhaus et al., 2001; Williams et
l., 1998).
The allosteric mechanism proposed here resolves
ractically all the discrepancies between the proposed
teric mechanism and functional studies of Rif inhibi-
ion. In particular, it explains the differential response of
ome rpoB mutants to Rifs in vivo, effects of Rif tails
n transcription in vitro, and the differential RFP resis-
ance of the holoenzymes with alternative σ factors
Wegrzyn et al., 1998). Finally, the RFP-induced loss of
he catalytic Mg2+ ion, rather than a simple steric hin-
rance of the RNA extension, helps to provide a unified
xplanation to a seemingly unrelated and surprising set
f observations, such as (1) inhibition by RFP of RNA
ynthesis and transcript cleavage (both are Mg2+ de-
endent) in the binary complexes (Altmann et al., 1994),
2) relief of RFP-dependent inhibition by elevated Mg2+
Figure 5 and Kerrich-Santo and Hartmann, 1974), and
3) potentiation of RFP effects in vivo by treating cells
ith Mg2+-chelating EDTA and EGTA (Sarubbi et al.,
004).
Propagation of the allosteric signal likely involves nu-
leic acid components of the transcription initiation
omplex. Our model of the open complex (Artsimovitch
t al., 2004) suggests that σHL likely interacts with the
emplate DNA strand, which may therefore participate
n the σ pathway. Subtle alterations of the same model
how that 5# NTP (or NMP) in the n-3 position of the
NA transcript (second bond formation) does not nec-
ssarily clash with bound Rif, as was suggested earlier
Campbell et al., 2001). Instead, its tri-phosphate (mono-
hosphate) moiety may make contacts with βArg529,
Arg687 and βThr525 (Thr and Arg in T. thermophilus,
espectively), and βAsp516 (Figure 6A). Their additional
nteractions with 5# RNA tri-/mono-phosphate might be
ssential to “switch on” the allosteric signal in the β
athway. In contrast, the 5#-terminal RNA nucleotide at
he n-2 position (first bond formation) would be too far
way to form similar modulatory contacts with the Rif
inding site residues. As a result, the allosteric modula-
ion of the active site destabilizing catalytic Mg2+ ion
ould not occur, thereby explaining why the β pathway
nhibits the second but not the first bond formation. It
s, however, worth noting that the proposed β pathway
echanism is hypothetical and a more specific analysis
s required to elucidate its details.
Another important question is the exact mechanism
y which the Rif-induced allosteric signal leads to the
educed affinity for the principal Mg2+ ion in the active
ite. We do not observe large systematic conforma-
ional changes in the active site upon Rifs’ binding that
ould exclude Mg2+ ion sterically and/or compromise
g2+ coordination bonds by moving apart the active-
ite Asp side chains. In contrast, in all four RNAP mole-
Allosteric Control of Transcription by Rifamycins
359Figure 6. β Subunit-Mediated Allosteric Signal
(A) A putative three-dimensional trace (stereo) of the signal (red arrows) that originates from the set of polar residues in the Rif binding site
(cyan) and is transmitted to the active site (white) through the intervening hydrophobic cluster (green). A model of the 4 bp (second bond is
formed) RNA/DNA hybrid (yellow/red) with the 5#-terminal RNA NTP (orange) is superimposed on the RNAP/RPN structure.
(B) Substitutions that disrupt Rif binding (βQ513P, βS531F) and the allosteric pathway (βL1325A) grow in the presence of RFP. Serial dilutions of
IPTG-induced cultures were plated on LB-Amp-IPTG in the absence and in the presence of 20 mg/l RFP and grown at 32°C. Pictures were
taken after 43 hr incubation.
(C) Both βQ513P and βL1325A enzymes are resistant to RFP in vitro, but only βL1325A retains RFP binding. Transcription was assayed on a T7A1
promoter encoded on a pIA171 template in the absence and in the presence of 2 g/ml RFP, as described in the Figure 5 legend. Binding
was assayed as described in Experimental Procedures. Data shown are the mean and SD (n = 3).
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360cules in the complex structures, the side chains of t
sβ#Asp460 and β#Asp464 are brought together some-
what closer than in the apo-holoenzyme, at a distance w
pof w2.4–2.55 Å (Figure 6A), suggesting their proton-
ation and a strong hydrogen bond formed between g
tthese residues in the presence of Rifs. The evidence for
such hydrogen bonding was provided by the extra- r
thigh-resolution (0.97 Å) structure of the periplasmic
phosphate receptor, in which two protonated acidic t
groups (Asp and phosphate) form a hydrogen bond
with unusually short distance (w2.4 Å) (Wang et al., r
t1997). Other systematic conformational differences be-
tween the RNAP/Rif complexes and the apo-holoen- m
szyme involve the side chains in the Rif binding site. The
most notable are the altered positions of the βArg529 t
cand βAsp516 side chains, which in all Rif complexes
form a stable hydrogen bond missing in the apo-holo- r
senzyme structure (Figure 6A), thereby inducing changes
in the extensive interaction network and likely in the f
5overall charge distribution in the vicinity of the Rif bind-
ing (Figure 6A); these charge alterations might be then b
ptransmitted further to change the local pKas of the
RNAP active site residues with no significant structural p
aalterations of the RNAP backbone and side chains.
Consistently, the βD516N substitution, which changes t
the chemical but not steric properties of the side chain,
confers strong Rif resistance (Figure S2). We speculate p
fthat the allosteric signal may result in protonation of
the active-site acidic residue(s) to favor the Asp-Asp s
thydrogen bonds that would compromise the catalytic
Mg2+ binding. e
f
cPerspectives for Drug Design
aThe major problem in the clinical use of rifamycins (and
eother antibiotics) is the rapid spread of bacteria bearing
oresistant mutations; in the case of Rifs, the vast major-
Iity of these mutations map to the rpoB gene. The func-
ttional analysis of Rif action in combination with the
whigh-resolution structural data illuminated the detailed
pRNAP/Rif interaction network at the atomic level and
revealed the crucial determinants of Rif binding in both
RNAP and Rifs. These data provide structural and C
Rmechanistic guidelines for development of new and im-
proved Rif derivatives. f
tAnalysis of the Rif-resistant variants (Figure 3) shows
that they fall into three categories: (1) “steric” mutants, g
σwhich reduce space in the Rif binding site and exclude
Rif through a steric clash with its backbone; (2) “affin- a
tity” mutants, which remove crucial protein polar/hydro-
phobic contacts with Rif; and (3) “allosteric” mutants, (
awhich interfere with the transmission of the Rif-induced
allosteric signal. Importantly, three positions altered in h
bw85% of clinical isolates represent all three categories:
βS531L,F,Y—steric, βH526X—affinity, and βD516V,G—alloste- D
iric (Figure 3; Table S1).
Most steric mutants attack the Rif portion consisting M
tof three planar rings, which cannot adopt any alterna-
tive conformation and are therefore exceedingly inflexi- c
ible. Moreover, this substructure defines to a large ex-
tent the overall Rif conformation. Thus, one apparent a
oway to decrease sensitivity to steric mutations is to re-
place the ring portion of Rif with a more flexible struc- d
oture retaining all the necessary hydrogen bonding de-erminants (O1, O2, O11) to make the inhibitor sterically
elf-adjustable to bulky substitutions in the protein,
hich would substantially modify the conformational
rofile of the binding site. Indeed, the antibiotic soran-
icin, which occupies the Rif binding site and mimics
he overall Rif conformation while lacking the Rif planar
ings and thus being more flexible, retains sensitivity
oward a number of the Rif-resistant steric RNAP mu-
ants (Campbell et al., 2005).
To decrease the effect of the affinity mutants, Rif de-
ivatives with additional groups that would provide ex-
ra contacts with the protein could be constructed. To
inimize the impact of specific RNAP steric and affinity
ubstitutions, these derivatives should bear polar groups
hat would form hydrogen bonds with the RNAP main
hain atoms, or flexible hydrophobic groups that would
ely on nonspecific van der Waals interactions. Our
tructural analysis allows us to suggest two such modi-
ications. First, the negatively charged pocket (β506–
13) exposing four main chain carbonyl oxygens may
ind to an additional Rif group with the complementary
ositive charge attached to C27. Second, the hydro-
hobic cavity formed by βMet459, βPhe505, βLeu511,
nd βPro535 may accommodate a hydrophobic tail at-
ached to C14.
Development of antibiotic derivatives that may com-
ensate for the allosteric mutations is not apparent
rom the structure and may therefore require an exten-
ive trial-and-error approach. However, our finding of
he σ pathway that likely relies on the Rif interactions
xclusively with the σ subunit σHL may substantially
acilitate the design of the allosterically insensitive
ompounds. The σ pathway is better protected against
llosteric resistance than the β pathway, as all bacteria
ncode several σ factors and simultaneous appearance
f Rif-resistant mutations in several genes is unlikely.
ndeed, all known Rif-resistant mutants are located in
he β subunit. Thus, construction of Rif derivatives that
ould amplify the signal in the σ pathway looks highly
romising.
oncluding Remarks
NAP is a powerful molecular motor that generates a
orce of w14 pN (Yin et al., 1995). An excellent illustra-
ion of its power is transcription initiation, in which a
rowing RNA/DNA hybrid displaces a large protein, the
subunit that binds to the core enzyme with nanomolar
ffinity (Gill et al., 1990) forming an extensive interface
hrough multiple polar and hydrophobic interactions
Vassylyev et al., 2002). It is not immediately clear why
proposed collision with a much smaller Rif molecule
aving similar binding affinity (Barh et al., 1976) would
e a much stronger antagonist of the nascent RNA/
NA hybrid extension. On the other hand, if the Rif-
nduced allosteric signal compromises the catalytic
g2+ ion binding it could affect inhibition of transcrip-
ion even before the RNA/DNA hybrid is long enough to
ollide with RNAP bound Rif (as can be the case with
nhibition of the first phosphodiester bond by RFB). As
weak Lewis acid, Mg2+ is ideally suited for catalysis
f phosphodiester bond formation, while precise coor-
ination by invariant Asp residues accounts for much
f the stereo- and enantioselectivity of the catalyzed
Allosteric Control of Transcription by Rifamycins
361reaction—thus even slight alterations of the Mg2+ ion
position could trigger a switch between different cata-
lytic pathways, for example, from nucleotide addition
to exonucleolytic cleavage. Repositioning of the Mg2+
ions in vicinity of the active site has recently emerged
as a common theme in regulation of RNAP by extrinsic
factors (Nickels and Hochschild, 2004); our data sug-
gest that transcriptional inhibitors may utilize similar
regulatory mechanisms.
Experimental Procedures
Structure Determination and Refinement
The ttRNAP holoenzyme was purified and crystallized as described
previously with the only exception that the pH value was slightly
shifted as compared to the previous crystallization conditions (from
5.8 to 6.5) (Artsimovitch et al., 2004; Vassylyev et al., 2002; Vassyl-
yeva et al., 2002). To obtain the complex crystals, the crystals of the
apo-holoenzyme were transferred for 4 hr into the drops containing
harvest buffer and 2 mM of RPN or RFB. The data for apo-holoen-
zyme and the ttRNAP/RFB and ttRNAP/RPN complexes were col-
lected at the beam line BL5 at Photon Factory (Tsukuba, Japan)
using ADSC Quantum-315 CCD detector. All the crystals, though
belonging to the same space group, P32, exhibited somewhat dis-
tinct unit cell parameters, a = b = 240 Å, c = 253 Å, as compared to
the previously studied ttRNAP crystals (a = b = 236 Å, c = 250 Å)
(Vassylyeva et al., 2002). The data were processed using HKL2000
data processing package (Otwinowski and Minor, 1997). The refine-
ment was carried out using the CNS program (Brunger et al., 1998).
The RPN and RFB models were built into the initial experimental
difference ED map (Figures 2C and 2D). The rigid body refinement
followed by several rounds of the B factor, positional, simulated
annealing refinements and water “pick” and water “delete” pro-
cedures, alternating by manual model building using the O program
(Jones et al., 1991), yielded the final R factors of 23.1%, 23.0%,
and 22.5% and Rfree of 26.8%, 26.7%, and 25.7% for the apo-holo-
enzyme, ttRNAP/RPN, and ttRNAP/RFB complexes, respectively
(Table 2). The final models were of high quality as revealed by the
simulated annealing omit ED maps calculated for RPN and RFB
(Figure S1). Three-dimensional structural figures were prepared
using programs Molscript (Kraulis, 1991), Bobscript (Esnouf, 1999),
and Raster3D (Merrit and Bacon, 1997).
Plating Efficiency Test
Overnight cultures of E. coli DH5α strain transformed with plasmids
encoding different rpoB variants under control of IPTG-inducible
Ptrc promoter grown in LB supplemented with 100 mg/l ampicillin
(Amp) were diluted 50-fold into fresh LB+Amp and grown to OD600
of 0.3 at 37°C. IPTG was added to 1 mM for 1.5 hr at 37°C (to allow
incorporation of the plasmid-encoded β into RNAP), and serial ten-
fold dilutions were made and spotted (in 7 l drops) on LB plates
supplemented with Amp (100 mg/l) and IPTG (1 mM). Different rifa-
mycins (or an equal volume of 50% ethanol) were added to 50
mg/l. MgSO4 was added where indicated. Plates were incubated at
32°C for 24 to 72 hr. The plating efficiency was calculated as the
ratio of viable cells grown on the plate supplemented with rifamycin
to that on the control plate (LB + Amp + IPTG). Plating efficiencies
were determined at least three times for each rpoB mutant under
the specified condition.
rpoB Mutagenesis and Core RNAP Purification
Desired mutations were introduced by site-directed mutagenesis
into the plasmid-encoded rpoB gene placed under control of IPTG-
inducible Ptrc promoter (pIA545 or pIA160). Random mutagenesis
was performed during PCR amplification with Taq DNA polymerase
in the presence of 0.5 mM MnCl2, followed by screening on LB +
Amp + IPTG plate supplemented with rifamycins. The region sur-
rounding each substitution was sequenced and transferred back
into the unmutagenized plasmid background. To create the expres-
sion vectors, NcoI-SdaI fragments of mutant rpoB genes were re-
cloned into pIA509 vector, which encodes the rpoA-rpoB-rpoC
gene cassette placed under control of T7 gene10 promoter (Artsi-movitch et al., 2003); the β subunit carries an N-terminal hexahisti-
dine tag. All plasmids used in this work are listed in Table S2. Core
RNAP-containing β substitutions were purified from a DH5α strain
transformed with pIA545 and derivative plasmids upon induction
with IPTG, followed by chromatography on Ni-NTA (Qiagen), Hepa-
rin HiTrap, and Q FF-sepharose columns using ACTA Prime LC
chromatography system (GE Healthcare). Core RNAP from pIA509-
derivative plasmids were purified from DH5α/λDE3 strain through
the same chromatographic steps. All proteins were dialyzed into
RNAP storage buffer (10 mM Tris, pH 7.9, 50% glycerol, 0.1 mM
EDTA, 0.1 mM DTT, 0.1 M NaCl) and stored at −20°C or −80°C.
rpoD Mutagenesis and  Subunit Purification
σ507-519 was constructed by site-directed mutagenesis. The muta-
genized region was sequenced and recloned into pIA586 to gener-
ate pIA582. Wild-type σ was purified from BL21/λDE3 transformed
with pETσ70 under denaturing conditions (Marr and Roberts, 1997)
using a combination of Ni-NTA agarose and heparin column chro-
matography; σ507-519 was purified from pIA582 similarly.
In Vitro Transcription
All templates for transcription reactions were generated by PCR
amplification. Holoenzymes containing wild-type or substituted β
or σ subunits were assembled from core RNAP and σ (1:2 molar
ratio) for 20 min at 32°C in storage buffer. To form an open complex,
linear DNA template (2 nM) and RNAP holoenzyme (50 nM) were
incubated at 37°C for 15 min in TGA buffer (20 mM Tris-acetate, 20
mM Na-acetate, 5% glycerol, 14 mM 2-mercaptoethanol, 2 mM
Mg-acetate, 0.1 mM EDTA, pH 8.0) unless noted otherwise. Then
rifamycins were added for 1 min, followed by incubation with sub-
strates, 100 M ApU, 2.5 M GTP, 1 M CTP, 10 Ci of [α32P]-CTP
(3000 Ci/mmol), at 37°C for 10–20 min. Reactions were terminated
by the addition of an equal volume of STOP buffer (10 M urea, 20
mM EDTA, 45 mM Tris-borate; pH 8.3), analyzed by denaturing gel
electrophoresis, visualized using Storm820 (GE Healthcare), and
quantified with Microsoft Excel or KaleidaGraph.
RFP Binding Assays
H3-labeled RFP (26.8 Ci/mmol, Moravek Biochemicals, Brea, Cali-
fornia) was mixed with E. coli RNAP holoenzymes (2 nM RFP to 10
nM RNAP) or initiation complexes in 1× TGA transcription buffer
and incubated at 37°C for 15 min. Five hundred microliters of the
binding reaction were loaded onto VivaSpin-500 100K filter and
concentrated w10×. The mix was washed twice with nine volumes
of binding buffer; the final retentate in case of negative control
(heat-denatured RNAP) contained <0.5% of the loaded radioactiv-
ity. Final retentate radioactivity was quantified using a liquid scintil-
lation counter. To evaluate effects of Mg2+ on RFP binding, EDTA
was omitted from the buffer and concentration of MgCl2 was ad-
justed to cover a 0.4–10 mM range both in the binding and wash
buffers.
Supplemental Data
Supplemental Data include text, three figures, two tables, and ref-
erences and can be found with this article online at http://www.cell.
com/cgi/content/full/122/3/351/DC1/.
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